Sculptra (Injectable Poly-L-Lactic Acid)

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 1, 2007, Pages 91-97

  Keni, Sanjay P ^a   Sidle, Douglas M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYALURONIC ACID; INDINAVIR; POLYLACTIC ACID; SILICONE; STAVUDINE;

ANTIVIRAL THERAPY; CLINICAL TRIAL; ESTHETICS; FOOD AND DRUG ADMINISTRATION; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOATROPHY; PATIENT CARE; PREVALENCE; REVIEW; SKIN GRAFT; SKINFOLD THICKNESS;

ADIPOSE TISSUE; ATROPHY; CELLULOSE; HIV INFECTIONS; HUMANS; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MANNITOL; POLYMERS; SKIN AGING;

EID: 33847130618     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2006.10.005     Document Type: Review

References (19)

1. Echavez M., and Horstman W. Relationship between lipoatrophy and quality of life. AIDS Read 15 7 (2005) 369-375
2. Sterling J.B., and Hanke C.W. Poly-L-lactic acid as a facial filler. Skin Therapy Lett 10 5 (2005) 9-11
3. Jones D. HIV facial lipoatrophy: causes and treatment options. Dermatol Surg 31 11 Pt 2 (2005) 1519-1529 [discussion: 1529]
4. Jones D.H., Carruthers A., Orentreich D., et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg 30 10 (2004) 1279-1286
5. Jones D. Approaches to treatment of HIV facial lipoatrophy. Skin Therapy Lett 10 9 (2005) 5-7
6. Funk E., Bressler F.J., and Brissett A.E. Contemporary surgical management of HIV-associated facial lipoatrophy. Otolaryngol Head Neck Surg 134 6 (2006) 1015-1022
7. Perry C.M. Poly-L-lactic acid. Am J Clin Dermatol 5 5 (2004) 361-366 [discussion: 367-8]
8. Valantin M.A., Aubron-Olivier C., Ghosn J., et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17 17 (2003) 2471-2477
9. Moyle G.J., Lysakova L., Brown S., et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5 2 (2004) 82-87
10. Gogolewski S., Jovanovic M., Perren S.M., et al. Tissue response and in vivo degradation of selected polyhydroxy acids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 27 9 (1993) 1135-1148
11. Brady J.M., Cutright D.E., Miller R.A., et al. Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res 7 2 (1973) 155-166
12. Engelhard PKM. Safety and efficacy of New-Fill (polylactic acid) in the treatment of HIV-associated lipoatrophy of the face (HALF). Presented at the XIV International AIDS Conference 2002. Barcelona, Spain, July 7-12, 2002.
13. Mest D.R.H.G. Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy. Antiviral Ther 9 (2004) 36
14. Burgess C.M., and Quiroga R.M. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 52 2 (2005) 233-239
15. Lafaurie M., Dolivo M., Porcher R., et al. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr 38 4 (2005) 393-398
16. Cattelan A.M., Bauer U., Trevenzoli M., et al. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy. Arch Dermatol 142 3 (2006) 329-334
17. Beljaards R.C., de Roos K.P., and Bruins F.G. NewFill for skin augmentation: a new filler or failure?. Dermatol Surg 31 7 Pt 1 (2005) 772-776 [discussion: 776]
18. (BPU) DL (injectable poly-L-lactic acid). Prescribing information. Dermik Laboratories, Berwyn (PA): August, 2004.
19. Engelhard P., Humble G., and Mest D. Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther 7 3-4 (2005) 201-205